Met Life Investment Management, LLC Tyme Technologies, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 12, 2023	BUY	$0.96 - $1.89 $49,484 - $97,421	51,546 New	51,546 $62.9 Million
Q2 2019 Aug 14, 2019	SELL	$0.96 - $1.89 $49,484 - $97,421	-51,546 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$1.76 - $3.73 $90,720 - $192,266	51,546 New	51,546 $90,000
Q4 2018 Jul 13, 2023	BUY	$2.01 - $4.21 $103,607 - $217,008	51,546 New	51,546 $190,000
Q4 2018 Mar 22, 2023	BUY	$2.01 - $4.21 $103,607 - $217,008	51,546 New	51,546 $190,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.21 $103,607 - $217,008	51,546 New	51,546 $190,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.